Nivalis Therapeutics (NVLS) Stock: Gaining On Merger News

Nivalis Therapeutics Inc (NASDAQ: NVLS) is having a pretty strong morning in the market this morning, and for good reason. The company announced a merger that’s exciting investors and sending the stock upward. As is almost always the case, our partners at Trade Ideas were the first to alert us to the gains.

NVLS Gains On Merger Announcement

As mentioned above, Nivalis Therapeutics is having a strong day after announcing merger news. The company will be merging with Alpine Immune Sciences, Inc. Alpine Immune Sciences is a privately held biotechnology company that’s focused on the development of novel therapeutics through its next-generation immune system modulation platform. In a statement, Howard Furst, Chairman of the Board at NVLS had the following to offer…

We believe this transaction with Alpine is an exciting path forward to advance important new therapies for patients and to create significant value for shareholders… Alpine, which has discovered novel ways to target the immune synapse, is led by a solid and experienced management team that has successfully brought immunotherapies to market.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on NVLS. In particular, we’re exciting to see the results of this merger. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required

Add Comment